Advertisement
Advertisement
STXS
Stereotaxis, Inc. Common Stock
1.04
USDSponsored
-0.01
-0.48%
Nov 06, 11:56 UTC -5
Open
Stereotaxis, Inc. Common Stock (STXS) Earnings
STXS Earnings Reports
Positive Surprise Ratio
STXS beat 14 of 26 last estimates.
54%
Next Report
Next Week
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$9.79M
/-$0.05
Implied change from Q2 26 (Revenue/ EPS)
+27.67%
/--
Implied change from Q3 25 (Revenue/ EPS)
+31.19%
/-28.57%
Stereotaxis, Inc. Common Stock earnings per share and revenue
On Aug 11, 2026, STXS reported earnings of -0.05 USD per share (EPS) for Q2 26, beating the estimate of -0.05 USD, resulting in a 1.96% surprise. Revenue reached 7.67 million, compared to an expected 8.52 million, with a -9.94% difference. The market reacted with a -4.11% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 9.79 million USD, implying an increase of 0.00% EPS, and increase of 27.67% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
FAQ
What were Stereotaxis, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Stereotaxis, Inc. Common Stock reported EPS of -$0.05, beating estimates by 1.96%, and revenue of $7.67M, -9.94% below expectations.
How did the market react to Stereotaxis, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -4.11%, changed from $1.46 before the earnings release to $1.40 the day after.
When is Stereotaxis, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Stereotaxis, Inc. Common Stock's next earnings report?
Based on 6
analysts, Stereotaxis, Inc. Common Stock is expected to report EPS of -$0.05 and revenue of $9.79M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.